With Rostermania taking the Apex community by storm, many are wondering which teams to look out for in ALGS Year 4 Split 2 ...

Shares of Aligos Therapeutics, Inc. (ALGS) have been struggling lately and have lost 8.1% over the past two weeks. However, a ...

Falcons have gotten straight down to business in their Apex Legends Global Series debut in the North America Split Two series ...

- Long-term extension data from LIVMARLI PFIC studies highlight improvement in key liver markers and growth ...

The Apex Legends Global Series Year 4 is heading into Split 2! The Split 1 Playoffs resulted in Reject Winnity coming out on top and the action is continuing th ...

The second half of the ALGS 2024 season has now begun, with the top teams from each of the four major leagues competing for a chance to represent their region on the international LAN stage at the ...

Presentations from studies evaluating LIVMARLI ® (maralixibat) oral solution in patients with Alagille syndrome (ALGS) and ...

Piper Sandler raised the price target for the Aligos Therapeutics Inc (NASDAQ:ALGS) stock from “a Neutral” to “an Overweight”. The rating was released on January 06, 2023, according to finviz. We ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Health Catalyst (HCAT – Research Report), Moderna (MRNA – Research Report) and Aligos Therapeutics (ALGS ...

A downtrend has been apparent in Aligos Therapeutics, Inc. (ALGS) lately with too much selling pressure. The stock has declined 13.7% over the past four weeks. However, given the fact that it is now ...